Industrial Select Sector SPDR (XLI) 55.77 $XLI Worst

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Industrial Select Sector SPDR (XLI) 55.77 $XLI

Worst Revenue And Earnings Declines Since Crisis Year 2009
Wolf Richter - at Seeking Alpha - Mon Mar 30, 8:16AM CDT
Stocks have soared. But despite maxed-out financial engineering and ceaseless Wall-Street hype, the first half is shaping up to be tough. Week after week, corporations and analysts have been whittling down their estimates. By now, revenues of the...
XLB: 48.78 (-0.49), XLP: 48.74 (-0.46), XLY: 75.35 (-0.33), XLK: 41.44 (-0.43), XLI: 55.77 (-0.56), XLU: 44.43 (+0.01), XLF: 24.11 (-0.17), XLV: 72.50 (-1.28), XLE: 77.58 (-0.46)

The Incredible Shrinking Earnings Forecast
Eric Parnell, CFA - at Seeking Alpha - Sun Mar 29, 1:18AM CDT

XLB: 48.78 (-0.49), XLP: 48.74 (-0.46), SPY: 206.43 (-1.82), XOM: 85.00 (-0.63), XLI: 55.77 (-0.56), XLF: 24.11 (-0.17), CVX: 104.98 (-1.92), XLE: 77.58 (-0.46)

Which Is Better: Cap-Weighting Or Equal-Weighting?
John Dowdee - at Seeking Alpha - Fri Mar 27, 3:56PM CDT

RYH: 155.22 (-2.05), RTM: 85.63 (-0.82), XLB: 48.78 (-0.49), RSP: 81.05 (-0.56), XLY: 75.35 (-0.33), XLU: 44.43 (+0.01), RYT: 91.90 (-0.69), XLV: 72.50 (-1.28), RYU: 74.25 (-0.30), XLP: 48.74 (-0.46), SPY: 206.43 (-1.82), RGI: 89.89 (-0.50), XLK: 41.44 (-0.43), RCD: 91.64 (-0.03), XLI: 55.77 (-0.56), RHS: 107.94 (-0.87), XLF: 24.11 (-0.17), RYE: 65.93 (-0.28), RYF: 44.56 (-0.18), XLE: 77.58 (-0.46)

Market Trend Analysis By Comparing Equal Weight To Market Weight Indexes
Richard Shaw - Seeking Alpha - Fri Mar 27, 10:20AM CDT
As a generality, a healthy stock market up trend has broad participation in the trend by a large or increasing portion of its constituents; and conversely an unhealthy market has a low or declining portion of it constituents participating in an up...
RYH: 155.22 (-2.05), XLB: 48.78 (-0.49), RTM: 85.63 (-0.82), RSP: 81.05 (-0.56), EWRS: 46.25 (+0.14), XLY: 75.35 (-0.33), QQEW: 43.80 (-0.43), XLU: 44.43 (+0.01), RYT: 91.90 (-0.69), XLV: 72.50 (-1.28), RYU: 74.25 (-0.30), IWB: 115.85 (-1.01), SPY: 206.43 (-1.82), QQQ: 105.60 (-1.13), RGI: 89.89 (-0.50), XLK: 41.44 (-0.43), RCD: 91.64 (-0.03), XLI: 55.77 (-0.56), RHS: 107.94 (-0.87), XLF: 24.11 (-0.17), RYE: 65.93 (-0.28), RYF: 44.56 (-0.18), XLE: 77.58 (-0.46), EWRI: 52.09 (-0.34)

Industrial Select Sector SPDR announces quarterly distribution of $0.261
Seeking Alpha - at Seeking Alpha - Fri Mar 20, 1:20PM CDT

XLI: 55.77 (-0.56)

U.S. Industrial Production: February 2015 Preview
James Picerno - Seeking Alpha - Mon Mar 16, 3:30AM CDT
U.S. industrial production is expected to increase 0.2% in Monday's February report versus the previous month, according to The Capital Spectator's median point forecast for several econometric estimates. The median prediction matches January's...
IYJ: 107.87 (-0.77), RGI: 89.89 (-0.50), UXI: 118.38 (-1.19), AIRR: 18.99 (-0.04), SIJ: 40.21 (+0.54), XLI: 55.77 (-0.56), FIDU: 28.80 (-0.24), VIS: 107.35 (-0.79), FXR: 31.16 (-0.18)

Healthcare's Relative Strength Persists As Broad Market Retreats
James Picerno - Seeking Alpha - Thu Mar 12, 5:40PM CDT
US equities have been trending lower so far in March, and no sector has been immune to the selling. But the relative strength in healthcare stocks continues to stand out. Energy companies, meanwhile, are still the weakest corner of the market among...
XLB: 48.78 (-0.49), XLP: 48.74 (-0.46), SPY: 206.43 (-1.82), VOX: 86.45 (-0.83), XLY: 75.35 (-0.33), XLK: 41.44 (-0.43), XLI: 55.77 (-0.56), XLU: 44.43 (+0.01), XLE: 77.58 (-0.46), XLV: 72.50 (-1.28)

Growth Of Global Food Output Reaches Post-Crisis High
Markit - Seeking Alpha - Mon Mar 09, 9:30AM CDT
Global sector PMI™ data from Markit signalled a record rate of growth in global food producer output in February. The sector was also the fastest-growing of all sectors monitored on a global basis in the latest period. Pharmaceuticals &...
XLB: 48.78 (-0.49), XLP: 48.74 (-0.46), XLY: 75.35 (-0.33), XLK: 41.44 (-0.43), PBJ: 32.44 (-0.23), XLI: 55.77 (-0.56), XLU: 44.43 (+0.01), XLF: 24.11 (-0.17), XLV: 72.50 (-1.28), XLE: 77.58 (-0.46)

ETF flows: Out of financials, industrials, tech; into energy, healthcare
Seeking Alpha - at Seeking Alpha - Thu Mar 05, 1:08PM CST

UYG: 145.21 (-1.94), ROM: 153.04 (-3.05), QTEC: 43.43 (-0.45), FXL: 35.76 (-0.34), ERY: 20.24 (+0.47), RGI: 89.89 (-0.50), TECL: 139.07 (-3.90), ERX: 54.83 (-1.37), FXN: 21.10 (-0.19), FXO: 23.62 (-0.09), FNCL: 28.76 (-0.15), FAS: 122.22 (-2.00), FAZ: 12.38 (+0.21), FXH: 67.02 (-0.98), SEF: 17.58 (+0.14), VFH: 49.28 (-0.29), DDG: 26.13 (+0.19), REW: 54.44 (unch), UXI: 118.38 (-1.19), SIJ: 40.21 (+0.54), TECS: 10.56 (+0.23), FIDU: 28.80 (-0.24), FTEC: 32.08 (-0.25), FENY: 22.19 (-0.17), RWW: 48.81 (-0.24), RXD: 12.72 (+0.14), OIH: 33.71 (-0.19), RXL: 141.39 (-3.75), AIRR: 18.99 (-0.04), DUG: 53.33 (+0.89), PXJ: 16.17 (-0.10), VIS: 107.35 (-0.79), XLK: 41.44 (-0.43), FHLC: 35.26 (-0.48), XLI: 55.77 (-0.56), XLF: 24.11 (-0.17), RYE: 65.93 (-0.28), RYF: 44.56 (-0.18), CURE: 147.07 (-6.72), VHT: 135.52 (-1.73), XLE: 77.58 (-0.46), IYW: 104.96 (-0.94), FINZ: 22.12 (+1.24), RYH: 155.22 (-2.05), VDE: 109.28 (-0.90), IYJ: 107.87 (-0.77), IYH: 154.32 (-2.24), IGM: 103.13 (-0.77), DIG: 50.65 (-0.88), FINU: 83.86 (-0.79), IYG: 89.49 (-0.34), RYT: 91.90 (-0.69), IYF: 89.05 (-0.48), IYE: 43.60 (-0.35), XLV: 72.50 (-1.28), FXR: 31.16 (-0.18), MTK: 100.34 (-0.67), VGT: 106.52 (-0.53)

Gathering Thin Reeds?
Jeffrey Saut - at Seeking Alpha - Tue Feb 24, 2:41AM CST
Many of you know that I spend time gathering "thin reeds" and try to weave them into a favorable "investment bouquet." This is a strategy Fidelity's Peter Lynch took to its zenith in an era gone by. Recall the story Peter told...
SPY: 206.43 (-1.82), QQQ: 105.60 (-1.13), DIA: 177.58 (-1.81), XLI: 55.77 (-0.56), XLV: 72.50 (-1.28)

Health Care/Biotech Names Still Dominating
Bespoke Investment Group - at Seeking Alpha - Tue Feb 24, 12:33AM CST
The average stock in the Russell 3,000 (which makes up roughly 98% of US-listed stocks) is now up 1.68% in 2015. Below we have calculated the average year-to-date performance of stocks by sector. As shown, Health Care stocks are up by far the most...
XLB: 48.78 (-0.49), XLY: 75.35 (-0.33), XLU: 44.43 (+0.01), XLV: 72.50 (-1.28), NFLX: 416.69 (-5.88), XLP: 48.74 (-0.46), EGLT: 12.93 (-0.16), FMI: 48.11 (-0.59), XLK: 41.44 (-0.43), XLI: 55.77 (-0.56), TWTR: 50.08 (+0.19), XLF: 24.11 (-0.17), XLE: 77.58 (-0.46)

What, Me Worry?
Eric Parnell, CFA - at Seeking Alpha - Wed Feb 18, 1:30PM CST

XLB: 48.78 (-0.49), XLP: 48.74 (-0.46), SPY: 206.43 (-1.82), XLY: 75.35 (-0.33), OIL: 10.05 (-0.22), XOM: 85.00 (-0.63), XLI: 55.77 (-0.56), CVX: 104.98 (-1.92), XLE: 77.58 (-0.46)

Energy And Utilities Swap Places
Bespoke Investment Group - at Seeking Alpha - Wed Feb 11, 11:52PM CST
As of Wednesday afternoon, 61% of stocks in the S&P 500 are trading above their 50-day moving averages. Readings over 50% mean breadth is positive, and right now nine of ten sectors are above this level. Interestingly, the one sector now without...
XLB: 48.78 (-0.49), XLP: 48.74 (-0.46), SPY: 206.43 (-1.82), XLY: 75.35 (-0.33), XLK: 41.44 (-0.43), XLI: 55.77 (-0.56), XLU: 44.43 (+0.01), XLF: 24.11 (-0.17), XLV: 72.50 (-1.28), XLE: 77.58 (-0.46)

The King Of Pain
Eric Parnell, CFA - at Seeking Alpha - Wed Feb 11, 3:01AM CST

XLB: 48.78 (-0.49), USO: 16.84 (-0.39), WMT: 82.25 (-0.28), XLU: 44.43 (+0.01), UUP: 25.90 (+0.04), EEM: 40.13 (-0.09), SPY: 206.43 (-1.82), GLD: 113.66 (-0.09), XLK: 41.44 (-0.43), COST: 151.49 (-0.88), EFA: 64.17 (-1.01), XLI: 55.77 (-0.56), IWM: 124.37 (-0.40), VNQ: 84.31 (-0.75), FXF: 100.23 (-0.33), UDN: 21.49 (-0.08), JJC: 32.84 (-0.58), JJA: 37.76 (-0.72)

Dull Industrial Earnings Put These ETFs In Focus
Zacks Funds - Seeking Alpha - Thu Jan 29, 3:47PM CST
As previously expected the Industrial sector has come out with lukewarm results for the fourth quarter earnings season. The major players in the space, such as General Electric (NYSE: GE ) , Caterpillar Inc. (NYSE: CAT ) and 3M Company (NYSE:...
MMM: 164.95 (-1.10), GE: 24.81 (-0.31), XLI: 55.77 (-0.56), CAT: 80.03 (-1.34), VIS: 107.35 (-0.79), UNP: 108.31 (-1.78)

Dull Industrial Earnings Put These ETFs in Focus - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Jan 29, 7:30AM CST
Lackluster results from some of the top industrial companies have dimmed the outlook for these ETFs.
IYJ: 107.87 (-0.77), MMM: 164.95 (-1.10), GE: 24.81 (-0.31), XLI: 55.77 (-0.56), CAT: 80.03 (-1.34), VIS: 107.35 (-0.79)

Sectors Most Exposed To The Oil Price
AlphaBetaWorks - Seeking Alpha - Fri Jan 23, 1:05PM CST
In periods of oil price volatility, there is much discussion of its impact on various industries. Market noise obscures true industry-specific performance, so oil's impact is impossible to judge from simple index returns. But, by stripping away...
BJK: 36.66 (-0.33), PXE: 29.62 (-0.15), XOP: 51.66 (+2.15), CARZ: 40.41 (-0.66), ITA: 123.78 (-1.06), IYR: 79.32 (-0.58), KIE: 67.09 (-0.34), XLI: 55.77 (-0.56), VNQ: 84.31 (-0.75), IEO: 73.36 (-0.65), VIS: 107.35 (-0.79)

Industrial ETF: XLI No. 6 Select Sector SPDR In 2014
J.J. McGrath - at Seeking Alpha - Thu Jan 15, 10:36AM CST

XLI: 55.77 (-0.56)

Sector Performance Since Tuesday's Highs
Bespoke Investment Group - at Seeking Alpha - Thu Jan 15, 1:11AM CST
Tuesday afternoon we highlighted the performance of the S&P 500 and its ten sectors off of the morning highs they put in. With the market taking another leg lower Wednesday, below is an updated look at the chart. The green bars represent the...
XLB: 48.78 (-0.49), XLP: 48.74 (-0.46), SPY: 206.43 (-1.82), XLY: 75.35 (-0.33), XLK: 41.44 (-0.43), XLI: 55.77 (-0.56), XLU: 44.43 (+0.01), XLF: 24.11 (-0.17), XLV: 72.50 (-1.28), XLE: 77.58 (-0.46)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 29

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 23

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 17

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 16

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 22

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 23

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

Context Therapeutics Gains Confidence with Strategic Developments

Updated Category News Views 60

Piper Sandler's Renewed Confidence in Context Therapeutics Piper Sandler has reiterated an Overweight rating for Context Therapeutics (NASDAQ: CNTX), maintaining a price target of $4.50 for the stock. This endorsement underscores their belief in the company’s potential within the biopharmaceutical sector. Positive Data from Competitors Enhances Expectations This renewed...

Continue Reading
Actinium's ATNM-400: A Promising Frontier in Prostate Cancer Therapy

Updated Category News Views 167

Introduction to ATNM-400's Innovative Approach Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) has announced compelling preclinical data showcasing its innovative treatment, ATNM-400. This first-in-class antibody radioconjugate targets a unique, non-PSMA antigen, revolutionizing prostate cancer therapy. ATNM-400 offers noteworthy therapeutic activity independent of...

Continue Reading
Opportunity Knocks: Ligon's Major Auction Up for Bids

Updated Category News Views 17

Equipment Auction Offers Unique Buying Opportunity Catch this: Ligon Co.'s auction is like finding a needle in a haystack in a world of overpriced equipment. We're talking about a smorgasbord of heavy machinery up for online grabs, and it’s happening until June 17. Auction Highlights: Your Next Business Asset? From telehandlers to trailers, this ain't your everyday yard...

Continue Reading
Selector Enhances Service Delivery with AWS Marketplace Launch

Updated Category News Views 147

Selector Launches on AWS Marketplace for Better Accessibility Selector, a pioneer in AI-driven observability and network intelligence, is transforming how organizations manage their network operations. The company has launched its flagship platform on the Amazon Web Services (AWS) Marketplace, which makes it easier for customers to procure and deploy its powerful AI tools...

Continue Reading
Exploring the Surge in Decentralized Energy Storage Growth

Updated Category News Views 229

Decentralized Energy Storage Market Overview The Decentralized Energy Storage market is gaining remarkable traction, with significant insights indicating a shift towards sustainable energy solutions. Valued at approximately USD 10.88 billion, the market is anticipated to expand to a staggering USD 35.62 billion, exhibiting a compound annual growth rate (CAGR) of 15.98%...

Continue Reading